| Announce Date | 10/22/2025 |
| EPS Normalized Actual | $25.77 (Beat by $17.24) |
| EPS GAAP Actual | $25.77 (Beat by $17.24) |
| Revenue Actual | $9.6758B |
| Revenue Surprise | Beat by $9675.8M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $8.71966 |
| EPS GAAP Estimate | $8.71966 |
| Revenue Estimate | $9.476864667B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 71.56 | 4.81 | 64.71903 | 79.45805 | 1 |
| Dec 2028 | 52.92 | 6.5 | 46.99384 | 58.78504 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -17.7 | -26.55 | 9.6758B | 4.7% | -431.54M |
| FQ2 2025 (Jun 2025) | 18.24 | 18.24 | 9.5829B | 3.66% | 9582.9M |
| FQ1 2025 (Mar 2025) | 7.96 | 7.96 | 9.1783B | 6.78% | 9178.3M |
| FQ4 2024 (Dec 2024) | 8.097 | 8.097 | 9.2221B | 16.78% | 9222.1M |
| FQ3 2024 (Sep 2024) | 21.94 | 21.94 | 9.2211B | 10.24% | 9221.1M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 9.2318B | 12.14% | 9231.8M |
| FQ1 2024 (Mar 2024) | 5.91 | 5.91 | 8.5564B | 18.5% | 8556.4M |
| FQ4 2023 (Dec 2023) | 7.74 | 7.74 | 7.6744B | 8.92% | 7674.4M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
8.71966
Consensus Revenue Estimates
9.476864667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 10.6 | -- | 10.11619 | 11.11297 | 3 |
| FQ3 2026 (Jul 2026) | 10.07 | 275.77 | 9.61038 | 10.55732 | 5 |
| FQ2 2026 (Jun 2026) | 9.28754 | -96.39 | 8.77718 | 9.74772 | 1 |
| FQ1 2026 (Mar 2026) | 8.71966 | 8.71 | 8.33235 | 9.0965 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 10.09B | -- | 9.73B | 10.46B | 4 |
| FQ3 2026 (Jul 2026) | 10.18B | 4.95 | 9.82B | 10.56B | 5 |
| FQ2 2026 (Jun 2026) | 9.92B | 3.41 | 9.5B | 10.3B | 2 |
| FQ1 2026 (Mar 2026) | 9.48B | 3.15 | 9.3B | 9.65B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 8.85 | -17.7 | -26.55 | 150% |
| FQ2 2025 (Jun 2025) | 18.24 | 18.24 | 100% | |
| FQ1 2025 (Mar 2025) | 7.96 | 7.96 | 100% | |
| FQ4 2024 (Dec 2024) | 8.097 | 8.097 | 100% | |
| FQ3 2024 (Sep 2024) | 21.94 | 21.94 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 5.91 | 5.91 | 100% | |
| FQ4 2023 (Dec 2023) | 7.74 | 7.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $10.11B | $9.68B | $-431.54M | -4.46% |
| FQ2 2025 (Jun 2025) | $0B | $9.58B | $9582.9M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $9.18B | $9178.3M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $9.22B | $9222.1M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $9.22B | $9221.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $9.23B | $9231.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $8.56B | $8556.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $7.67B | $7674.4M | 100% |